A groundbreaking study has made a significant breakthrough in understanding the causes of spinal degeneration, a major contributor to chronic back pain. Researchers at the Universities of Edinburgh and Bristol discovered a genetic link to the condition and found that an existing osteoporosis drug can prevent mineral buildup in the spine. This finding could lead to new treatments for the millions of people worldwide who suffer from back pain. The study used zebrafish as a model to investigate the genetic and molecular mechanisms underlying spinal degeneration. The researchers found that a specific gene associated with collagen IX, a protein that maintains the structural integrity of spinal discs, was linked to the condition. They also discovered that the absence of this gene led to abnormal mineral deposits and spinal fusion in the zebrafish. The team then tested various approaches to reduce spinal damage in the zebrafish and found that a medication belonging to the bisphosphonate class, already used to treat osteoporosis, was effective in blocking the abnormal mineral buildup. This is a significant finding, as it suggests that a treatment already used in patients could be repurposed to address spinal degeneration. The study also identified other potential targets for future treatments, including fat metabolism and phosphate regulation. The researchers found that limiting food intake and suppressing fat metabolism also reduced spinal damage in the zebrafish. While the study was conducted in zebrafish and more research is needed to confirm the findings in humans, the results are promising and offer new hope for treating chronic back pain. The study's lead researcher, Dr. Erika Kague, emphasized the potential significance of identifying treatments that target the underlying causes of spinal damage. The findings have significant implications for the millions of people worldwide who suffer from back pain. The study's results could lead to the development of new treatments that slow or prevent spinal degeneration, improving the quality of life for those affected by this debilitating condition.